journal
https://read.qxmd.com/read/36921646/the-association-between-pcsk9-inhibitor-use-and-sepsis-a-systematic-review-and-meta-analysis-of-20-double-blind-randomized-placebo-controlled-trials
#1
JOURNAL ARTICLE
Zhen Zhou, Wei Zhang, David Burgner, Andrew Tonkin, Chao Zhu, Chenyu Sun, Costan G Magnussen, Michael E Ernst, Monique Breslin, Stephen J Nicholls, Mark R Nelson
AIMS: To determine the impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor use on incident sepsis and other severe infections. METHODS: We searched PubMed, EMBASE, CENTRAL and ClinicalTrial.gov up to September 14, 2021 for double-blind, placebo-controlled randomized trials of alirocumab, evolocumab, or inclisiran with >100 participants in each arm and report of serious adverse events related to infection. Data were synthesized with the fixed-effect Mantel-Haenszel model to generate risk ratios (RRs) with 95% confidence intervals (CIs) of each outcome for PCSK9 inhibitor versus placebo...
March 13, 2023: American Journal of Medicine
https://read.qxmd.com/read/36906170/gender-equality-in-national-cardiology-societies-a-cross-sectional-study
#2
JOURNAL ARTICLE
Svenja Ravioli, Jolanda Oberle, Michael Haidinger, Gregor Lindner
BACKGROUND: Higher productivity and team stability has been shown for gender diverse teams. However, there is a relevant and well-known gender gap in clinical and academic cardiovascular medicine. So far, no data concerning gender distribution in presidents and executive boards of national cardiology societies exist. METHODS: In this cross-sectional analysis, gender equality in presidents and representatives of all national cardiology societies, which are members of or affiliated with the European Society of Cardiology (ESC) in 2022 was analyzed...
March 9, 2023: American Journal of Medicine
https://read.qxmd.com/read/36906169/chatgpt-in-scientific-writing-a-cautionary-tale
#3
EDITORIAL
Haoyi Zheng, Huichun Zhan
No abstract text is available yet for this article.
March 9, 2023: American Journal of Medicine
https://read.qxmd.com/read/36906168/morning-distort
#4
EDITORIAL
Martin A Samuels
No abstract text is available yet for this article.
March 9, 2023: American Journal of Medicine
https://read.qxmd.com/read/36906167/report-from-the-retreat-on-meaningful-use
#5
EDITORIAL
Martin A Samuels
No abstract text is available yet for this article.
March 9, 2023: American Journal of Medicine
https://read.qxmd.com/read/36898600/the-impact-of-nirmatrelvir-ritonavir-in-reducing-hospitalizations-among-high-risk-patients-with-sars-cov-2-during-the-omicron-predominant-era
#6
JOURNAL ARTICLE
Mohanad M Al-Obaidi, Ahmet B Gungor, Sangeetha Murugapandian, Bijin Thajudeen, Iyad Mansour, Ryan C Wong, Bekir Tanriover, Tirdad T Zangeneh
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has caused significant morbidity and mortality in high-risk populations. Several therapeutics have been developed to reduce the risk of COVID-19 related complications, hospitalizations, and death. In several studies, nirmatrelvir-ritonavir (NR) was reported to reduce the risk of hospitalizations and death. We aimed to evaluate the efficacy of NR in preventing hospitalizations and death during the Omicron predominant period. METHODS: We retrospectively evaluated patients from June 1, 2022, through September 26, 2022...
March 8, 2023: American Journal of Medicine
https://read.qxmd.com/read/36898599/cme-is-it-meeting-the-mark
#7
EDITORIAL
Sruthi Ranganathan, Vinay Prasad
No abstract text is available yet for this article.
March 8, 2023: American Journal of Medicine
https://read.qxmd.com/read/36893832/a-treatment-naive-cancer-patient-in-critical-condition
#8
Nicolas Peruzzo, Jeziel Basso, Pedro Grachinski Buiar, Gustavo Gössling, Gilberto Schwartsmann
No abstract text is available yet for this article.
March 7, 2023: American Journal of Medicine
https://read.qxmd.com/read/36893831/controversies-in-hypertension-iii-dipping-nocturnal-hypertension-and-the-morning-surge
#9
REVIEW
Edward J Filippone, Andrew J Foy, Gerald V Naccarelli
A comprehensive approach to hypertension requires out-of-office determinations by home and/or ambulatory monitoring. The 4 phenotypes comparing office and out-of-office pressures in treated and untreated patients include normotension, hypertension, white-coat phenomena, and masked phenomena. Components of out-of-office pressure may be equally as important as mean values. Nighttime pressures are normally 10 - 20% lower than daytime (normal "dipping"). Abnormalities include dipping more than 20% (extreme dippers), less than 10 % (non-dippers), or rising above daytime (risers) and have been associated with elevated cardiovascular risk...
March 7, 2023: American Journal of Medicine
https://read.qxmd.com/read/36889497/the-evolution-of-cardiovascular-ultrasound-a-review-of-cardiac-point-of-care-ultrasound-pocus-across-specialties
#10
REVIEW
Amer M Johri, Casey Glass, Braeden Hill, Trevor Jensen, Wilfredo Puentes, Olusegun Olusanya, Juana Nicoll Capizzano, Ria Dancel, Kreegan Reierson, Nathaniel Reisinger, Kiera Liblik, Benjamin T Galen
The use of cardiac point-of-care ultrasound (POCUS) is now widespread in clinics, emergency departments, and all areas of the hospital. Users include medical trainees, advanced practice practitioners, and attending physicians in many specialties and sub-specialties. Opportunities to learn cardiac POCUS and requirements for training vary across specialties as does the scope of the cardiac POCUS examination. In this review, we describe both a brief history of how cardiac POCUS emerged from echocardiography and the state of the art across a variety of medical fields...
March 6, 2023: American Journal of Medicine
https://read.qxmd.com/read/36889496/a-glimpse-into-a-life
#11
JOURNAL ARTICLE
Jason E Liebowitz
No abstract text is available yet for this article.
March 6, 2023: American Journal of Medicine
https://read.qxmd.com/read/36889495/not-so-fast-on-virtual-interviewing
#12
EDITORIAL
Christopher Nabors, Abhay Dhand, Andrea Porrovecchio, Melissa Gennarelli, William Frishman
No abstract text is available yet for this article.
March 6, 2023: American Journal of Medicine
https://read.qxmd.com/read/36889494/extensive-nonbacterial-thrombotic-endocarditis-with-recurrent-strokes-as-a-manifestation-of-diffuse-scleroderma
#13
Abhinav Karan, Hui Jun Guo, Michael Omar, Spencer Streit
No abstract text is available yet for this article.
March 6, 2023: American Journal of Medicine
https://read.qxmd.com/read/36889493/the-management-of-sarcoidosis-in-the-2020-s-by-the-primary-care-physician
#14
REVIEW
Marc A Judson
Sarcoidosis is an idiopathic granulomatous disease that occurs worldwide and may affect any organ. Because the presenting symptoms of sarcoidosis are not specific for the disease, the primary care physician is usually the first provider to assess these patients. In addition, patients who have previously been diagnosed with sarcoidosis are usually followed longitudinally by primary care physicians. Therefore, these physicians are often the first to address sarcoidosis patient symptoms related to exacerbations of the disease, as well as first observe complications of sarcoidosis medications...
March 6, 2023: American Journal of Medicine
https://read.qxmd.com/read/36889492/new-drugs-approved-in-2022
#15
REVIEW
Alex M Ebied, Hesham Elmariah, Rhonda M Cooper-DeHoff
In 2022, the US Food and Drug Administration (FDA) approved 37 novel drugs. Twenty four of the 37 (65%) novel drug approvals were reviewed and approved through an expedited review pathway and 20 of the 37 (54%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2022.
March 6, 2023: American Journal of Medicine
https://read.qxmd.com/read/36889491/system-citizenship-re-envisioning-the-physician-role-as-part-of-the-sixth-wave-of-professionalism
#16
JOURNAL ARTICLE
Jed D Gonzalo, Ami L DeWaters, Britta Thompson, Lindsay Mazotti, Nardine Riegels, Robert Cooney, James B Reilly, Terry Wolpaw, Daniel R Wolpaw
No abstract text is available yet for this article.
March 6, 2023: American Journal of Medicine
https://read.qxmd.com/read/36871752/pre-race-aspirin-to-enhance-primary-prevention-of-marathon-related-cardiac-arrests-confronting-pheidippides-legacy
#17
EDITORIAL
Arthur J Siegel
No abstract text is available yet for this article.
March 3, 2023: American Journal of Medicine
https://read.qxmd.com/read/36849070/clinical-utility-of-routine-use-of-fungal-blood-cultures
#18
EDITORIAL
Lauren Nicholas Herrera, Ryan Khodadadi, Sixto Leal, Prathit Kulkarni, Peter Pappas, Todd McCarty
No abstract text is available yet for this article.
February 25, 2023: American Journal of Medicine
https://read.qxmd.com/read/36841321/above-the-threshold-time-of-coagulation-delayed-diagnosis-of-acquired-hemophilia-a
#19
JOURNAL ARTICLE
Mayu Kikuchi, Yukinori Harada, Ayano Hamai, Sachi Takaoka
No abstract text is available yet for this article.
February 23, 2023: American Journal of Medicine
https://read.qxmd.com/read/36828215/a-rapidly-progressive-aortic-aneurysm-due-to-escherichia-coli
#20
Ken Nagahata, Hiroyuki Kamiya, Hiroki Takahashi
No abstract text is available yet for this article.
February 22, 2023: American Journal of Medicine
journal
journal
22674
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.